SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-004540
Filing Date
2016-05-13
Accepted
2016-05-13 13:58:36
Documents
43
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q033116.htm 10-Q 276648
2 EX-31.1 ex31-1.htm EX-31.1 8465
3 EX-31.2 ex31-2.htm EX-31.2 8514
4 EX-32.1 ex32-1.htm EX-32.1 3208
5 EX-32.2 ex32-2.htm EX-32.2 3371
  Complete submission text file 0001185185-16-004540.txt   1713627

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mzei-20160331.xml EX-101.INS 198432
7 XBRL TAXONOMY EXTENSION SCHEMA mzei-20160331.xsd EX-101.SCH 23631
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mzei-20160331_cal.xml EX-101.CAL 22533
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mzei-20160331_def.xml EX-101.DEF 120796
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mzei-20160331_lab.xml EX-101.LAB 177670
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mzei-20160331_pre.xml EX-101.PRE 122233
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 161647483
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries